S-Space

Browse

Publisher

Showing results 1 to 4 of 4

Issue Date	Title / Author(s) / Citation	File
2011-12	Epigenetic-Based Therapies in Cancer Progress to Date Song, Sang-Hyun; Han, Sae-Won; Bang, Yung-Jue Drugs, Vol.71 No.18, pp.2391-2403	DOI
2017-04	Regional Differences in Serotonin Transporter Occupancy by Escitalopram: An [C-11] DASB PK-PD Study Kim, Euitae; Howes, Oliver D.; Kim, Bo-Hyung; Chon, Myong-Wuk; Seo, Seongho; Turkheimer, Federico E.; Lee, Jae Sung; Lee, Yun-Sang; Kwon, Jun Soo Clinical Pharmacokinetics, Vol.56 No.4, pp.371-381	DOI
2022-11	Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate Kim, Ji Min; Kim, Binnari; Kim, Eunji; Jang, Minsun; Cho, Jun Hun; Lee, Hye Seung; Kwak, Yoonjin; Huang, Lingkang; Krishnan, Radha; Bai, Sally Y.; Mounawar, Mounia; Kim, Kyoung-Mee Molecular Diagnosis and Therapy, Vol.26 No.6, pp.679-688	DOI
	Evaluation of the Effect of Lorlatinib on CYP2B6, CYP2C9, UGT, and P-Glycoprotein Substrates in Patients with Advanced Non-Small Cell Lung Cancer Chen, Joseph; Bearz, Alessandra; Kim, Dong-Wan; Mamdani, Hirva; Bauman, Jessica; Chiari, Rita; Ou, Sai-Hong Ignatius; Solomon, Benjamin J.; Soo, Ross A.; Felip, Enriqueta; Shaw, Alice T.; Thurm, Holger; Clancy, Jill S.; Lee, Kimberly; O'Gorman, Melissa; Tanski, Cherie; Pithavala, Yazdi K. Clinical Pharmacokinetics, Vol.63 No.2, pp.171-182	DOI